Gene therapy firms need to consider patients when choosing a viral vector production method, say researchers behind new economic analysis.
Pluristyx leaders outline how better starting materials, automation, and process control can scale iPSC manufacturing.
Catalytic reactive-hydrogen membranes capture and break down six PFAS in water, achieving up to 96% removal and 83% ...
Roche and Hansoh Pharmaceutical Group have launched their second collaboration focused on developing cancer-fighting antibody ...
The companies plan to first optimize Takara's SMART-seq RNA-seq library prep workflows on SPT Labtech's firefly liquid ...
There is hope that extremophile bioprospecting could aid discovery of next-generation drug therapeutics by biotech innovators ...
PacBio and Verily Health will integrate HiFi long-read sequencing with health data and cloud tools to support biomedical ...
IMU Biosciences and UK Biobank will profile 80,000 blood samples using technologies from Waters and Ultima Genomics.
Diasome is preparing to advance its HDV-insulin formulation into pivotal studies after generating positive Phase IIb data in type 1 diabetes (T1D) earlier this year and presenting it at two ...
This proceedings eBook, developed in partnership with GEN (Genetic Engineering & Biotechnology News) and Cincinnati Children’s Hospital Applied Gene and Cell Therapy Center, captures perspectives and ...
Investigators say research in breast organoids demonstrates a new way to study how environmental exposures may affect normal human tissue before cancer develops.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results